|
| |
How to Balance Your Body to Get Pregnant
Traditional Chinese Medicine (TCM) has been treating fertility successfully for over two thousand years, long before Assisted Reproductive Technology (ART) was a glimmer in anyone's eye. Since more and more couples are encountering the very emotional and ...
Maca-Herb - The Herb For Boosting Energy
MACA -HERB If you'd like a boost in your workout, or something to make your day glide by more energetically, you need look no further; Maca Herb is all you need. Maca Herb is the highest altitude-cultivated crop in the world. Related to the turnip, it ...
Ready to Lose Your Glasses? Ten tips to choosing a LASIK or Laser Vision Correction Center
Ready To Lose Your Glasses? Ten Tips To Choosing A LASIK or Laser Vision Correction Center The world of ophthalmology is one of the fastest evolving fields of medicine. Never before have so many new techniques and scientific breakthroughs emerged in such ...
|
|
|
| |
Now, however, Dr Jacob and Dr Gutowski of the Royal Devon and Exeter Hospital, with support from the Peninsula Medical School, are working on a new approach that causes cancer cells to self-destroy: effectively to commit suicide. In a project that started in 2000 (first with funding from the UK Research Council funding, then from the Leverhulme Trust and involvement of Exeter Antioxidant Therapeutics Ltd) the research has led to the discovery of catalysts that mimic the activity of a certain human enzyme (glutathione peroxidase). They work by setting off reactions in the cancer cells causing them to kill themselves. A crucial benefit of this approach is that the drugs target only diseased cells, leaving healthy ones intact. This means that any therapy based on this approach should avoid many of the risks and side effects associated with chemotherapy and radiotherapy. The treatment is also highly efficient because, as Dr Jacob says, 'catalysts are not consumed during their activity but are recycled over and over again. This means that only minute quantities of biocatalyst are needed to kill cancer cells.'
Dr Jacob goes on to explain that the principle to make cancer cells kill themselves 'is based on the fact that catalysts are not only effective, but also highly selective:
'We knew from previous research (by us and others) that cancer cells have their own "biochemical signature" and that we could design catalysts that recognise this signature and use it to kill cells. We have also looked at natural human defence systems - and they use a similar catalytic chemistry.'
Of course many different types of cancers exist and the crucial question many will ask is what kinds of cancers could be treated by this method in the future? At this stage in the research the catalysts have been shown to work with cancer cells containing elevated concentrations of so-called 'reactive species'. Cancers that are known to have these species are human prostate and kidney cancer and certain lung carcinomas. The content of reactive species in several other kinds of cancer cells is still not fully determined.
As existing cancer treatments are associated with risks to healthy cells as well as the cancerous ones, recent research worldwide has been concentrating on the design of drugs that specifically target cancer cells and leave healthy cells alone. Such treatments lower the side effects of the drugs significantly, but unfortunately not completely. 'Our approach,' says Dr Jacob, 'uses catalysts to achieve this goal. Catalysts are very different from "one shot" conventional drugs since they facilitate reactions of species already present within the cancer cell and themselves are therefore recycled. This means they are active in very small
concentrations. Since they "need" the cancer cell's reactive species for activity, they are only active in cancer cells but not in normal cells.'
The compounds have been developed and synthesised at Exeter University''s School of Biological and Chemical Sciences and tested in cancer cells at the Royal Devon and Exeter Hospital and the research is now entering its critical phase. The team has just started with animal tests and hopes to proceed to clinical trials once the compounds have shown activity in the animal models. They have teamed up with Exeter Antioxidant Therapeutics Ltd. and this company is providing patent protection and is negotiating with larger pharmaceutical companies to develop and test these catalysts further. Since this approach is based on a new method rather than a single new compound, it has considerable potential for the development of a range of new catalysts with anticancer potential.
Although the research team stresses that treatment based on this approach is still many years off, their findings open up valuable new directions in the field of anti-cancer research.
For further information, please contact:
Claus Jacob
University of Exeter
C.Jacob@exeter.ac.uk
Note about Dr Jacob:
Dr Claus Jacob moved to Exeter from Harvard Medical School in 1999 and has worked for several years at the Chemistry/Medicine interface. He has published numerous research papers on the importance of oxidative stress
in health and disease.
About the Author
Brenda is a British writer and editor living in France. Find out more about her work at her web site: www.worldsapartreview.com.
|
|
|
|
|
|
|
|
 Positron Announces Posi Rx ™ Program for a Total Solution in Cardiac ... - Businesswire.com
HOUSTON--( BUSINESS WIRE )--Positron Corporation (OTCBB:POSC) announced today that they will market its complete turnkey offering of radiopharmaceuticals, camera service and imaging for a total solution to customers under the name Posi Rx ...
Brain pacemaker helps Parkinson's, but with risks - Guardian Unlimited
Associated Press Writer= CHICAGO (AP) â Parkinson's sufferers who had electrodes implanted in their brains improved substantially more than those who took only medicine, according to the biggest test yet of deep brain stimulation. The study ...
Weakening Demand from US, Europe and Japan Likely to Be Offset By ... - Yahoo Finance
SINGAPORE, Jan. 7 /PRNewswire/ -- The credit crisis and ongoing economic slowdown across major economies like US, Europe and Japan has impacted the semiconductor industry. There has been considerable slowdown in chip sales as more than half of ...
News Releases - Boston University
(Boston)-A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the ...
How big Jurassic flying reptiles got off ground - WTOP Radio
This undated handout illustration provided by The Johns Hopkins University shows the massive 30-foot wingspan of the toothless pteranodon, left, was surpassed by that of Hatzegopteryx, right, at 40 feet or more. Pterosaurs, sometimes weighed more ...
|
